Biosimilars: State of Clinical and Regulatory Science.

@article{Klein2017BiosimilarsSO,
  title={Biosimilars: State of Clinical and Regulatory Science.},
  author={Agnes Victoria Klein and Jian Wang and Brian G Feagan and Mark Omoto},
  journal={Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques},
  year={2017},
  volume={20 1},
  pages={
          332-348
        }
}
On May 12, 2017, various issues and challenges associated with biologics were discussed during a session of the annual joint conference of Canadian Society for Pharmaceutical Sciences and Canadian Chapter of Controlled Release Society at Hyatt Regency Hotel, Montréal, QC, Canada.  An update on the Canadian regulatory guidelines for biosimilars was given, followed by viewpoints expressed by regulatory, academic and industry scientists.  Topics of discussion included: reference biologic drug… CONTINUE READING